These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37052231)

  • 21. Cerebrolysin: a review of its use in dementia.
    Plosker GL; Gauthier S
    Drugs Aging; 2009; 26(11):893-915. PubMed ID: 19848437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrolysin protects PC12 cells from CoCl2-induced hypoxia employing GSK3β signaling.
    Hartwig K; Fackler V; Jaksch-Bogensperger H; Winter S; Furtner T; Couillard-Despres S; Meier D; Moessler H; Aigner L
    Int J Dev Neurosci; 2014 Nov; 38():52-8. PubMed ID: 25093704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monitoring of neurotrophic factors and cognitive function in patients with traumatic brain injury].
    Karakulova YV; Selyanina NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):34-37. PubMed ID: 29171486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-restricted release of multiple neurotrophic factors promotes axonal regeneration and functional recovery after peripheral nerve injury.
    Huang L; Xia B; Shi X; Gao J; Yang Y; Xu F; Qi F; Liang C; Huang J; Luo Z
    FASEB J; 2019 Jul; 33(7):8600-8613. PubMed ID: 30995417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together with cerebrolysin attenuates traumatic brain injury induced exacerbation of brain pathology in Parkinson's disease.
    Ozkizilcik A; Sharma A; Feng L; Muresanu DF; Tian ZR; Lafuente JV; Buzoianu AD; Nozari A; Wiklund L; Sharma HS
    Int Rev Neurobiol; 2023; 171():83-121. PubMed ID: 37783564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat.
    Sharma HS; Muresanu DF; Patnaik R; Stan AD; Vacaras V; Perju-Dumbrav L; Alexandru B; Buzoianu A; Opincariu I; Menon PK; Sharma A
    J Nanosci Nanotechnol; 2011 Sep; 11(9):7549-69. PubMed ID: 22097459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective, multi-center cohort study evaluating the severity- related effects of cerebrolysin treatment on clinical outcomes in traumatic brain injury.
    Muresanu DF; Ciurea AV; Gorgan RM; Gheorghita E; Florian SI; Stan H; Blaga A; Ianovici N; Iencean SM; Turliuc D; Davidescu HB; Mihalache C; Brehar FM; Mihaescu AS; Mardare DC; Anghelescu A; Chiparus C; Lapadat M; Pruna V; Mohan D; Costea C; Costea D; Palade C; Bucur N; Figueroa J; Alvarez A
    CNS Neurol Disord Drug Targets; 2015; 14(5):587-99. PubMed ID: 25924999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of neurotrophic factors in Alzheimer's Disease.
    Nasrolahi A; Javaherforooshzadeh F; Jafarzadeh-Gharehziaaddin M; Mahmoudi J; Asl KD; Shabani Z
    Mol Biol Rep; 2022 Mar; 49(3):2345-2357. PubMed ID: 34826049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide.
    Sharma HS; Muresanu DF; Castellani RJ; Nozari A; Lafuente JV; Buzoianu AD; Sahib S; Tian ZR; Bryukhovetskiy I; Manzhulo I; Menon PK; Patnaik R; Wiklund L; Sharma A
    Prog Brain Res; 2021; 265():1-97. PubMed ID: 34560919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms of neurotrophic and neuroprotective effects of cerebrolysin in cerebral ischemia].
    Gromova OA; Torshin IIu; Gogoleva IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(3 Pt 2):43-50. PubMed ID: 24781241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke.
    Zhang L; Chopp M; Meier DH; Winter S; Wang L; Szalad A; Lu M; Wei M; Cui Y; Zhang ZG
    Stroke; 2013 Jul; 44(7):1965-72. PubMed ID: 23696546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T; Vernay L
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD007026. PubMed ID: 27918088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature.
    Gruenbaum SE; Zlotnik A; Gruenbaum BF; Hersey D; Bilotta F
    CNS Drugs; 2016 Sep; 30(9):791-806. PubMed ID: 27339615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possibilities of neurotrophic therapy in early recovery after stroke].
    Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(8. Vyp. 2):84-89. PubMed ID: 31825367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T; Vernay L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007026. PubMed ID: 28430363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.
    Zhang Y; Zhang ZG; Chopp M; Meng Y; Zhang L; Mahmood A; Xiong Y
    J Neurosurg; 2017 Mar; 126(3):782-795. PubMed ID: 28245754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIF-1α and VEGF Are Involved in Deferoxamine-Ameliorated Traumatic Brain Injury.
    Wang K; Jing Y; Xu C; Zhao J; Gong Q; Chen S
    J Surg Res; 2020 Feb; 246():419-426. PubMed ID: 31630885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrolysin improves symptoms and delays progression in patients with Alzheimer's disease and vascular dementia.
    Allegri RF; Guekht A
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():25-41. PubMed ID: 22514793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrolysin alleviates early brain injury after traumatic brain injury by inhibiting neuroinflammation and apoptosis via TLR signaling pathway.
    Lu W; Zhu Z; Shi D; Li X; Luo J; Liao X
    Acta Cir Bras; 2022; 37(6):e370605. PubMed ID: 36074398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.